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Androgen Signaling in the 
Placenta
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Abstract
The placenta is a multifunctional, transitory organ that mediates transport of 
nutrients and waste, gas exchange, and endocrine signaling. In fact, placental secre-
tion of hormones is critical for maintenance of pregnancy, as well as growth and 
development of healthy offspring. In this chapter, the role of androgens in placental 
development and function is highlighted. First, a brief summary will be provided 
on the different mammalian placental types followed by an overview of placental 
steroidogenesis. Next, the chapter will focus on genomic and non-genomic androgen 
signaling pathways. Finally, an overview will be provided on the current status of 
androgen signaling in the placenta during normal and abnormal pregnancies.
Keywords: pregnancy, placenta, testosterone, dihydrotestosterone, androgen 
receptor
1. Introduction
Establishing and maintaining pregnancy requires a finely regulated series of 
physiological events involving mother, fetus, and placenta. The essential role of 
steroid hormones in the production and maintenance of many of these changes is 
well characterized. For example, important effects of progesterone include prepara-
tion of the endometrium for implantation [1], modulation of the maternal immune 
response to tolerate the fetal allograft, maintenance of myometrial quiescence [2], and 
preparation of mammary glands for lactation. Estrogens appear to influence uterine 
blood flow and neovascularization, increase the expression of critical proteins that 
are involved in progesterone production and steroid metabolism and participate in 
preparation of mammary glands for lactation [3, 4]. Throughout pregnancy, levels 
of maternal circulating androgens, including testosterone (T), dihydrotestosterone 
(DHT), dehydroepiandrosterone (DHEA) and androstenedione (A4) increase, with 
concentrations three-fold higher by the third trimester when compared to non-
pregnant levels in women [5]. Although T is a well-known precursor for estrogens 
(E2) synthesis, the placenta can both be a source and a target for androgens. The goal 
of this chapter is to summarize what is known about androgens and androgen receptor 
in pregnancy and compare it between species and between different types of placenta.
2. Placenta classification
The placenta is a multifunctional, transitory organ that mediates transport 
of nutrients and waste, gas exchange, and endocrine signaling. In fact, placental 
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secretion of hormones is critical for maintenance of pregnancy, as well as growth 
and development of a healthy offspring. Despite fulfilling similar functions, there is 
a wide range of diversity in placental anatomo-histology among species.
During early embryogenesis, the first cells to differentiate are trophoblast cells, 
which form the chorion or fetal portion of the placenta. Villous trophoblast cells 
have two distinct cell populations; undifferentiated cytotrophoblast cells and dif-
ferentiated syncytiotrophoblast tissue. The syncytiotrophoblast tissue is a continu-
ous, multinucleated, specialized layer of epithelial cells, which covers the villous 
surface and is in direct contact with maternal blood. This layer is formed by fusion 
of cytotrophoblast cells.
Placental gross morphological classification is based on the shape and the area 
of contact between fetal and maternal tissue [6]. There are four commonly describe 
placental shapes among mammals:
1. Diffuse placenta, present in the horse and pig, has chorionic villi in contact 
with the uterine endometrium throughout the entire surface of the allanto-
chorion, forming either folds (pig) or microcotyledons (horse).
2. Cotyledonary placenta, present in ruminants, is made up of multiple discrete 
areas of attachment called cotyledons, which are formed by the interaction 
between the fetal allantochorion and the maternal endometrium. The fetal 
side of this type of placenta is called cotyledons, the maternal side is called 
caruncles, and the cotyledon-caruncle complexes are known as placentomes.
3. Zonary placenta, present in carnivores such as dogs and cats, has the shape of 
a complete (dog and cat) or incomplete band (ferrets and raccoons) of tissue 
surrounding the chorionic sack.
4. Discoid placenta, present in rodents and primates, is formed by a collection of 
villi on a single (mice and human) or double (rabbit) disc.
In addition to the gross morphological classification, placentas are also categorized 
by histology (Figure 1) which is based on the different number of cell layers separating 
fetal from maternal circulation [7]. Before the placenta is formed, there are a total of 
six layers of tissue separating maternal and fetal blood. Three of these layers are fetal 
extraembryonic membranes in the chorioallantoic placenta of all mammals, all of 
which are components of the mature placenta. These three layers include endothelium 
lining allantoic capillaries, connective tissue in the form of chorioallantoic mesoderm, 
and chorionic epithelium, derived from trophoblast cells. There are also three layers 
on the maternal side, but the number of these layers which are retained after placenta-
tion varies greatly among species. The three potential maternal layers in a placenta are 
endothelium lining endometrial blood vessels, connective tissue of the endometrium, 
and endometrial epithelial cells.
Based on this degree of separation, or number of layers separating the fetal and 
maternal tissues, there are four different types of placenta (see Figure 1):
1. Epitheliochorial placenta, present in pig and horse, consists of all six layers 
separating maternal from fetal blood throughout gestation. The trophoblast 
cells make contact with the uterine epithelium forming microcotyledons 
(horse) or chorionic folds (pig). Microcotyledons contain highly vascularized 
chorionic villi that extend into elaborate invaginations of the endometrium. 
Chorionic folds are formed by the lining of the chorionic villi into the wrinkled 
surface of the uterine epithelium.
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2. Synepitheliochorial placenta, present in ruminants, contains the same layers 
as an epitheliochorial placenta. In this type of placenta, the uterine epithelium 
is modified by invasion and fusion of binucleate cells forming the syncytium, 
which contains embryonic and maternal nuclei. More recently, multinucleated 
trophoblast giant cells (TGC), formed by incomplete cytokinesis of mono-
nucleated trophoblast cells, are believed to remove endometrial epithelial cells 
and fuse and contribute to the syncytial trophoblast layer [8].
3. Endotheliochorial placenta, present in carnivores (cats and dogs), is formed 
when the endometrial epithelium is disrupted during placentation, and fetal 
chorionic epithelial cells come in contact with maternal endothelial cells. 
Figure 1. 
Histological classification of the placenta.
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During implantation, cytotrophoblast cells surround the central third of the 
chorioallantois and proliferate to form a syncytium called the syncytiotro-
phoblast layer. The syncytiotrophoblast layer erodes through the endometrial 
epithelium and grows around maternal capillaries. Initially, the invading fetal 
cells are in the form of villi, but villi soon coalesce to form a labyrinthine-type 
placenta. For this reason, only four tissue layers separate the maternal from the 
fetal blood.
4. Hemochorial placenta, present in humans and rodents, is the most invasive 
form of placentation. Fetal chorionic epithelium is bathed in maternal blood 
because chorionic villi have invaded through endometrial epithelium and 
eroded through maternal endothelium. The number of trophoblast layers in 
contact with the maternal circulation shows variation between species. It is 
hemomonochorial in humans, with one layer of syncytiotrophoblast, and 
hemodichorial in primates, with one layer of syncytiotrophoblast upon one 
layer of cytotrophoblast cells. Finally, it is hemotrichorial in rodents with one 
layer of cytotrophoblast and two layers of syncytiotrophoblast separating 
maternal and fetal blood.
3. Placenta steroidogenesis
A key function of the placenta is the secretion of hormones. Like other steroid 
hormones, T is derived from cholesterol and the synthesis involves several enzy-
matic steps. The first and fundamental step in its biosynthesis involves the oxida-
tive breakdown of the cholesterol side chain by the enzyme P450scc (side-chain 
cleavage), a mitochondrial cytochrome oxidase, resulting in the loss of six carbon 
atoms to give rise to pregnenolone. Only certain cell types in humans are capable of 
pregnenolone synthesis, including testicular Leydig cells, ovarian theca and corpus 
luteal cells, placental trophoblast cells, cells of the adrenal cortex, and specific cells 
in the brain, such as the pyramidal and granular neurons of the hippocampus and 
the Purkinje cells from the cerebellum [9]. The resulting pregnenolone is either 
converted to progesterone or 17 α-hydroxypregnenolone via 3β-hydroxysteroid 
dehydrogenase (HSD3B) or cytochrome P450 17A1 (CYP17A1), respectively. 
Progesterone is secreted into maternal circulation, and 17α-hydroxypregnenolone 
can be metabolized to DHEA via CYP17A1. DHEA is oxidized into A4 via HSD3B. 
A4 is then reduced to 5 α-androstenedione via 5 α-reductase (SRD5A). DHEA and 
A4 can be converted by 17 β-hydroxysteroid dehydrogenase into androstenediol and 
T, respectively. Subsequently, T is converted into DHT via 5 α-reductase (SRD5A). 
T and 5 α-androstenedione can further be metabolized to estrogens via aromatase 
(CYP19A1) [10]. A summarized overview of placental steroidogenesis is provided 
in Figure 2.
Androgens are synthesized in tissues where 17α-hydroxylase/17,20-lyase cyto-
chrome P450 (P450c17) exists. This enzyme is located in different tissues such as 
fetal and maternal adrenal glands, fetal ovaries and testes, and the corpus luteum, 
depending on to the animal species. In non-pregnant woman, 50% of all DHEA 
is secreted by the adrenal glands, 20% from the ovarian theca and 30% is derived 
from metabolism of circulating DHEA sulfate [11]. Adrenal glands and ovaries 
produce equal amounts of A4, with the total daily production rate 1.4-6.2 mg/
day [12]. 50% of T is synthesized in the ovaries and adrenals and the other half 
is produced from A4 in the peripheral tissues. Daily production rate of T in non-
pregnant women is in the order of 0.1–0.4 mg/day. Finally, the conversion of T to 
5
Androgen Signaling in the Placenta
DOI: http://dx.doi.org/10.5772/intechopen.94007
DHT occurs in peripheral tissues, such as ovaries and skin, with a daily production 
rating between 4.3 and 12.5 mg/day.
During pregnancy, an additional source of androgens comes from the fetus and 
placenta (Figure 2). Androgens are principally synthesized in the corpus luteum 
during early stages of gestation in rats and dogs and this function is taken over by 
the placenta in late stages of gestation in rats [13]. In sheep and goats, P450c17 is 
present in the placenta [14]. Some studies revealed that the absence of P450c17 in 
human and horse placentas results in negligible androgen synthesis [15]. However, 
protein and mRNA levels of CYP17A1 have been detected in primary human tropho-
blast cells and the human trophoblast cell line JEG-3 and trophoblast cells were able 
to generate testosterone de novo [16]. Placentas associated with a male fetus at term 
have increased expression of 5 α-reductase compared to a female fetus [17]. This 
enzyme is involved in reducing T to DHT, a potent androgen with a higher binding 
affinity to AR than T, suggesting the placenta may play a role in the hormonal differ-
ences between pregnancies between female and male fetuses.
In horses, the placenta does not appear to express P450c17 and thus cannot 
convert de novo c21 progestogens (pregnenolone and progesterone) to the c19 
androgens (DEHA and A4). In this case, the fetal gonads are the main androgen 
source as estrogens precursor during mid to late gestation in the horse. Removal 
of fetal gonads results in an immediate fall in maternal plasma concentrations 
of conjugated and unconjugated estrogens whereas progestogens levels remain 
unchanged [18].
Figure 2. 
Summarized overview of the functional interaction between the placental, maternal and fetal compartments 
for the biosynthesis of progesterone, estrogens and androgens by the human placenta. Progesterone is produced 
mainly from maternal cholesterol. Progesterone can be metabolized into DHEA by the maternal and fetal 
adrenal gland. DHEA can be converted into T. Subsequently, T can further be metabolized to estrogens via 
aromatase (CYP19A1). In horses, the placenta does not appear to express P450c17 and thus cannot convert de 
novo c21 progestogens (pregnenolone and progesterone) to the c19 androgens (DEHA and A4). It is for this 
reason that the reaction occurs in the fetal adrenal.
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4. Androgen signaling and placenta function
To exert a cellular response, steroid hormones need to bind to either a membrane 
receptor or an intracellular, nuclear or cytoplasmic receptor. T and DHT can bind to 
either type of receptor, AR (encoded by AR, in the human Xq11-12), or a membrane-
bound receptor, such as G protein-coupled receptor family C group 6 member A 
(GPRC6A) [19]. DHEA and A4 require conversion to T or DHT to exert their andro-
genic effects.
AR is expressed at all levels of the female hypothalamic-pituitary-gonadal 
axis, including the brain, ovarian stroma, ovarian follicles and corpus luteum. 
Furthermore, AR is present in first trimester and term placenta, and localizes to 
the cytosol of placental villi, and in cytotrophoblast, differentiated syncytiotro-
phoblast, and placental stroma [20]. In ruminant placentomes, nuclear signals 
are predominantly observed in invasive TGC and uninucleate trophoblast cells, 
stromal cells of the chorionic villi, caruncular epithelial, and stromal cells during 
late gestation [21, 22].
AR belongs to the steroid hormone intracellular receptor family. Exon 1 of the 
AR gene encodes the N-terminal domain, which contains an activation function 1 
(AF1) region that interacts with coregulatory proteins to enhance transcriptional 
regulation of AR target genes. Exons 2 and 3 encode two distinct zinc-fingers 
(DNA-binding domain) required for interaction with a palindromic androgen 
response elements (ARE) of the core sequence, 5′-TGTTCT-3′, separated by 3 
nucleotides located within the promoter regions of AR target genes. The remaining 
exons encode a hinge region which contains the nuclear localization signal, and the 
ligand binding domain [23].
When localized to the cytoplasm, AR is bound by a number of chaperone 
proteins including heat shock protein 90 (Hsp90) as well as immunophilins. When 
ligands, T or DHT, bind to AR, there is a conformational change which exposes 
the nuclear localization signal, allowing the interaction with importin-α, which 
facilitates nuclear translocation. Once inside the nucleus, two subunits of the AR 
dimerize and bind the ARE on promoter regions of AR-target genes, resulting in 
transcriptional regulation, leading to either activation or suppression of expression. 
Co-regulatory proteins, such as histone lysine demethylases (KDMs), modulate 
transcriptional activity of AR-target genes. In sheep for example, KDMs have been 
found to act as co-regulators in trophoblast cells [22, 24]. This interaction with 
regulator factors is critical for signaling processes in the placenta.
Androgens are known to stimulate proliferation of human umbilical vein 
endothelial cells, indicating a key role for androgens during pregnancy. During 
establishment of pregnancy, androgens play a role in embryo implantation. Early in 
pregnancy, before implantation, T is converted to DHT which regulates transcrip-
tion of factors necessary for initiation of decidualization and early endometrial 
receptivity. Near the time of implantation, T itself promotes endometrial remodel-
ing, and soon after implantation it serves as an important precursor for E2 which 
regulates vascular remodeling [25]. Studies in mice reveal that insufficient andro-
gens may delay embryo implantation, whereas excess androgens lead to aberrant 
gene expression at implantation sites.
Studies on ovine placentas revealed vascular endothelial growth factor A 
(VEGFA) expression to be androgen responsive, and androgens are thought to 
regulate the expression of VEGFA and play a key role in placental angiogenesis 
[21, 23]. More specifically, AR and the KDM1A coregulator are recruited to an 
ARE in the ovine VEGFA promoter. On gestational day 90, placenta VEGFA 
mRNA and VEGFA and AR protein levels increased in testosterone-treated ewes 
compared to control placentas [22].
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In addition to the classical genomic intracellular AR mediated signaling 
pathways, androgens also act through membrane receptors. GPRC6A is a G 
protein-coupled receptor (GPCR) that functions as a membrane receptor for small 
amino acids, cations, osteocalcin, and androgens [26]. GPRC6A is known to have 
a long extracellular domain to allow for the binding of these different ligands 
[26]. GPRC6A mediates the effects of osteocalcin, a protein hormone released by 
osteoblasts, and results in the activation of the cAMP pathway and subsequently, 
testosterone synthesis by the Leydig cells of the testis. GPRC6A ligand binding can 
result in the activation of the Gαs, Gαi, and Gαq pathways (Figure 3). The presence 
of GPRC6A has been identified in placental trophoblast cell membranes, indicating 
the possibility of androgens eliciting a non-genomic effect on cells of the placenta.
Another membrane receptor that androgens elicit a non-genomic effect through 
is Zrt- and Irt-like protein 9 (ZIP9) [27]. ZIP9 is a zinc transporter that also acts as 
a receptor for androgens via G-protein coupling. Studies have revealed the presence 
of ZIP9 in ovarian tissue of Atlantic croakers, and act as a receptor for androgens 
inducing apoptosis in follicular cells, as well as promoting zinc uptake. Studies also 
show a similar action in breast and prostate tissue [28]. Ultimately, these two studies 
reveal that androgens binding to ZIP9 results in the activation of pro-apoptotic 
genes and the regulation of zinc homeostasis within target tissues [28].
Similarly, Transient receptor potential cation channel subfamily M (melastatin) 
member 8 (TRPM8) and Oxoeicosanoid receptor 1 (OXER1) bind a variety of 
ligands including androgens [29]. However, their expression during pregnancy or in 
placental cells is currently unknown.
5. Androgens and pregnancy
Androgens play a fundamental role in female physiology, particularly during 
pregnancy. In women, androgens are synthesized by cells within the ovaries, the 
adrenal glands, fat, and also in placenta, acting in an endocrine or paracrine fashion 
[30]. DHEA, mainly from the adrenal glands, acts as a crucial precursor for E2 and T 
in the ovary and other target tissues such as fat [31]. Depending on the intracellular 
availability of steroidogenic enzymes in target tissues, DHEA is converted to A4 
Figure 3. 
Androgen signaling through GPRC6A in target tissue. Image created with BioRender.com.
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which is a precursor for T, both of which can be aromatized to estrogens [32]. Some 
studies have reported an elevated level of T during pregnancy. An increase in T levels 
occurs from the first trimester of pregnancy, becoming more pronounced towards 
the third trimester, being three-folds higher than observed in non-pregnant women 
(Table 1) [36]. In contrast, maternal circulating DHEA levels decrease in pregnant 
women due to it being converted to T and E2 [37].
Steroid production varies widely among species, with these differences becoming 
more pronounced during pregnancy. Each species have their own distinct pattern of 
steroid serum levels, steroidogenic enzymes, receptors, and transporters to support 
their individual physiological requirements. For example, in dairy cows, maternal 
serum T levels increase ~100-fold during the last trimester of gestation (Table 1), as 
well as a ~50-fold increase in milk testosterone levels [38].
In the horse, T elevation during pregnancy presents a biphasic curve (Table 1). 
The first elevation is caused by luteal androgen production, which is stimulated by 
equine chorionic gonadotropin (eCG). The late rise and fall are temporally related 
to the development and regression, respectively, of the fetal gonads. The equine 
placenta has little capacity to synthesize androgens, as it lacks CYP17A1. Hence, 
androgens in the form of DHEA are substrates for E2 synthesis, and must be sup-
plied mostly by fetal gonads, forming a true feto-placental unit [39].
As androgen levels increase during pregnancy, the mother and develop-
ing fetuses usually are protected from excess bioactive androgens by increased 
secretion of sex hormone-binding and placental aromatase, which converts T 
into E2. Hyperandrogenism can result from a number of conditions, the most 
common being luteomas and theca-lutein cysts within the ovary. Luteomas are 
benign tumors that occur during pregnancy with excess androgen production in 




1st trimester 1.34 0.66
2nd trimester 1.98 0.73















Testosterone serum levels during pregnancy in human [33], horses [34], and cows [35].
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Additional causes of excess androgen production during pregnancy are conditions 
such as polycystic ovarian syndrome (PCOS), one of the most common endocrine 
disorders in women of reproductive age, and congenital adrenal hyperplasia (CAH). 
Both conditions result in pregnancy complications, including pregnancy induced 
hypertension and pre-eclampsia, a human pregnancy syndrome characterized by 
the onset of hypertension and proteinuria after 20 weeks of gestation, and can lead 
to maternal or fetal mortality [42]. In humans, clinical observations have established 
that women with PCOS exhibit similar features as seen in classical 21-hydroxylase 
deficiency in CAH, such as anovulation, ovarian hyperandrogenism, LH hypersecre-
tion, polycystic appearing ovaries, and insulin resistance, despite normalization 
of adrenal androgen excess after birth [43]. Furthermore, animal studies have 
demonstrated that intrauterine exposure to excessive amounts of androgens can 
lead to development of PCOS after birth (reviewed in [44, 45]). In fact, prenatal 
androgenization in pregnant ewes has revealed reproductive and metabolic pheno-
types in female offspring that closely resemble PCOS in women. These observations 
suggest that androgen excess during early life, whether derived from fetal or maternal 
sources, may provide one possible mechanism to explain the occurrence of PCOS in 
adulthood.
Less common causes leading to androgen excess during pregnancy include 
placental aromatase deficiency. Aromatase is encoded by the CYP19A1 gene, and 
is responsible for converting T to E2. At least 10 different promoters have been 
identified in its regulatory region, enabling regulation in a tissue-specific man-
ner [46]. Mutations in CYP19A1 prevent aromatization of testosterone, leading 
to hyperandrogenism and phenotypes similar to androgen excess, including 
maternal and fetal virilization and development of ambiguous genitalia at birth 
[47]. Of particular interest is the observation that placental aromatase deficiency 
is associated with pre-eclampsia [48, 49]. Women with pre-eclampsia have signifi-
cantly lower levels of placental aromatase, and significantly lower levels of both 
17β-estradiol:testosterone and estrone:androstenedione ratios, as well as higher 
levels of T. In fact, this placental defect in steroidogenesis appears before clinical 
symptoms of pre-eclampsia and thus may serve as a diagnostic marker.
6. Conclusions
The focus of this chapter was on androgens and their potential role in pregnancy 
and placental development and function. Normal pregnancy in women is associated 
with increased maternal serum levels of androgens, which are derived from the 
adrenal glands, adipose tissue, ovaries, and placenta. Species differences in andro-
gen production exist reflecting species-specific needs for pregnancy maintenance 
and/or placental function. Furthermore, the placenta contains classical androgen 
receptors as well as non-classical membrane receptors, indicating the placenta is 
a target of androgen signaling. Preliminary and ongoing studies suggest a role for 
androgen signaling in trophoblast cell differentiation and placental angiogenesis.
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